Lyon P, Keijzer F, Arendt D and Levin M: Reframing cognition: Getting down to biological basics. Philos Trans R Soc Lond B Biol Sci. 376(20190750)2021.PubMed/NCBI View Article : Google Scholar

Harvey PD: Domains of cognition and their assessment. Dialogues Clin Neurosci. 21:227–237. 2019.PubMed/NCBI View Article : Google Scholar

Gómez-Gómez ME and Zapico SC: Frailty, cognitive decline, neurodegenerative diseases and nutrition interventions. Int J Mol Sci. 20(2842)2019.PubMed/NCBI View Article : Google Scholar

McNicholas N, O'Connell K, Yap SM, Killeen RP, Hutchinson M and McGuigan C: Cognitive dysfunction in early multiple sclerosis: A review. QJM. 111:359–364. 2018.PubMed/NCBI View Article : Google Scholar

Elendu C, Amaechi DC, Elendu TC, Ibhiedu JO, Egbunu EO, Ndam AR, Ogala F, Ologunde T, Peterson JC, Boluwatife AI, et al: Stroke and cognitive impairment: Understanding the connection and managing symptoms. Ann Med Surg (Lond). 85:6057–6066. 2023.PubMed/NCBI View Article : Google Scholar

Lo JW, Crawford JD, Desmond DW, Bae HJ, Lim JS, Godefroy O, Roussel M, Kang Y, Jahng S, Köhler S, et al: Long-Term cognitive decline after stroke: An individual participant data meta-analysis. Stroke. 53:1318–1327. 2022.PubMed/NCBI View Article : Google Scholar

Cho MH, Shin DW, Chang SA, Lee JE, Jeong SM, Kim SH, Yun JM and Son K: Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia. Sci Rep. 8(11688)2018.PubMed/NCBI View Article : Google Scholar

Helvik AS, Barca ML, Bergh S, Šaltytė-Benth J, Kirkevold Ø and Borza T: The course of depressive symptoms with decline in cognitive function-A longitudinal study of older adults receiving in-home care at baseline. BMC Geriatr. 19(231)2019.PubMed/NCBI View Article : Google Scholar

Jain N, Wang Y, Zhang Y, Jacobsen E, Andreescu C, Snitz BE, Chang CH and Ganguli M: It goes both ways: The relationship between anxiety and mild cognitive impairment. Int J Geriatr Psychiatry. 38(e5899)2023.PubMed/NCBI View Article : Google Scholar

Kwon KY, Park S, Kim RO, Lee EJ and Lee M: Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease. Sci Rep. 12(11461)2022.PubMed/NCBI View Article : Google Scholar

Pais R, Ruano L, P Carvalho O and Barros H: Global cognitive impairment prevalence and incidence in community dwelling older adults-A systematic review. Geriatrics (Basel). 5(84)2020.PubMed/NCBI View Article : Google Scholar

Tahami Monfared AA, Byrnes MJ, White LA and Zhang Q: The humanistic and economic burden of Alzheimer's disease. Neurol Ther. 11:525–551. 2022.PubMed/NCBI View Article : Google Scholar

Lin PJ and Neumann PJ: The economics of mild cognitive impairment. Alzheimers Dement. 9:58–62. 2013.PubMed/NCBI View Article : Google Scholar

Xu T, Dong W, Liu J, Yin P, Wang Z, Zhang L and Zhou M: Disease burden of Parkinson's disease in China and its provinces from 1990 to 2021: Findings from the global burden of disease study 2021. Lancet Reg Health West Pac. 46(101078)2024.PubMed/NCBI View Article : Google Scholar

Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, et al: Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 26:1816–1821. 2020.PubMed/NCBI View Article : Google Scholar

Epstein MA, Achong BG and Barr YM: Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1:702–703. 1964.PubMed/NCBI View Article : Google Scholar

Hoover K and Higginbotham K: Epstein-Barr Virus. In: StatPearls (Internet). StatPearls Publishing, Treasure Island, FL, 2024.

Li Q and Cohen JI: Epstein-Barr virus and the human leukocyte antigen complex. Curr Clin Microbiol Rep. 6:175–181. 2019.PubMed/NCBI View Article : Google Scholar

Yin H, Qu J, Peng Q and Gan R: Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol. 208:573–583. 2019.PubMed/NCBI View Article : Google Scholar

Zhang N, Zuo Y, Jiang L, Peng Y, Huang X and Zuo L: Epstein-Barr virus and neurological diseases. Front Mol Biosci. 8(816098)2022.PubMed/NCBI View Article : Google Scholar

Drouin E and Drouin G: The first report of Alzheimer's disease. Lancet Neurol. 16(687)2017.PubMed/NCBI View Article : Google Scholar

van der Flier WM, de Vugt ME, Smets EMA, Blom M and Teunissen CE: Towards a future where Alzheimer's disease pathology is stopped before the onset of dementia. Nat Aging. 3:494–505. 2023.PubMed/NCBI View Article : Google Scholar

Hampel H, Mesulam MM, Cuello AC, Khachaturian AS, Vergallo A, Farlow MR, Snyder PJ, Giacobini E and Khachaturian ZS: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research. J Prev Alzheimers Dis. 6:2–15. 2019.PubMed/NCBI View Article : Google Scholar

Sobue A, Komine O and Yamanaka K: Neuroinflammation in Alzheimer's disease: Microglial signature and their relevance to disease. Inflamm Regen. 43(26)2023.PubMed/NCBI View Article : Google Scholar

Schreiner TG and Popescu BO: Amyloid beta dynamics in biological fluids-Therapeutic impact. J Clin Med. 10(5986)2021.PubMed/NCBI View Article : Google Scholar

Muralidar S, Ambi SV, Sekaran S, Thirumalai D and Palaniappan B: Role of tau protein in Alzheimer's disease: The prime pathological player. Int J Biol Macromol. 163:1599–1617. 2020.PubMed/NCBI View Article : Google Scholar

Patrick KL, Bell SL, Weindel CG and Watson RO: Exploring the ‘multiple-hit hypothesis’ of neurodegenerative disease: Bacterial infection comes up to bat. Front Cell Infect Microbiol. 9(138)2019.PubMed/NCBI View Article : Google Scholar

Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L and Licastro F: Herpes virus in Alzheimer's disease: Relation to progression of the disease. Neurobiol Aging. 35:122–129. 2014.PubMed/NCBI View Article : Google Scholar

Shim SM, Cheon HS, Jo C, Koh YH, Song J and Jeon JP: Elevated Epstein-Barr virus antibody level is associated with cognitive decline in the Korean elderly. J Alzheimers Dis. 55:293–301. 2017.PubMed/NCBI View Article : Google Scholar

Huang SY, Yang YX, Kuo K, Li HQ, Shen XN, Chen SD, Cui M, Tan L, Dong Q and Yu JT: Herpesvirus infections and Alzheimer's disease: A Mendelian randomization study. Alzheimers Res Ther. 13(158)2021.PubMed/NCBI View Article : Google Scholar

Leonardo S and Fregni F: Association of inflammation and cognition in the elderly: A systematic review and meta-analysis. Front Aging Neurosci. 15(1069439)2023.PubMed/NCBI View Article : Google Scholar

Tiwari D, Singh VK, Baral B, Pathak DK, Jayabalan J, Kumar R, Tapryal S and Jha HC: Indication of neurodegenerative cascade initiation by amyloid-like aggregate-forming EBV proteins and peptide in Alzheimer's disease. ACS Chem Neurosci. 12:3957–3967. 2021.PubMed/NCBI View Article : Google Scholar

Jakhmola S and Jha HC: Glial cell response to Epstein-Barr Virus infection: A plausible contribution to virus-associated inflammatory reactions in the brain. Virology. 559:182–195. 2021.PubMed/NCBI View Article : Google Scholar

Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, et al: Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 577:399–404. 2020.PubMed/NCBI View Article : Google Scholar

Tiwari D, Mittal N and Jha HC: Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation. Curr Res Neurobiol. 3(100046)2022.PubMed/NCBI View Article : Google Scholar

Koseoglu MM, Norambuena A, Sharlow ER, Lazo JS and Bloom GS: Aberrant neuronal cell cycle re-entry: The pathological confluence of Alzheimer's Disease and brain insulin resistance, and its relation to cancer. J Alzheimers Dis. 67:1–11. 2019.PubMed/NCBI View Article : Google Scholar

Malhotra N, Gupta R and Kumar P: Pharmacological relevance of CDK inhibitors in Alzheimer's disease. Neurochem Int. 148(105115)2021.PubMed/NCBI View Article : Google Scholar

Sun X, Zhang H, Yao D, Xu Y, Jing Q, Cao S, Tian L and Li C: Integrated bioinformatics analysis identifies hub genes associated with viral infection and Alzheimer's disease. J Alzheimers Dis. 85:1053–1061. 2022.PubMed/NCBI View Article : Google Scholar

Mizutani K, Miyata M, Shiotani H, Kameyama T and Takai Y: Nectin-2 in general and in the brain. Mol Cell Biochem. 477:167–180. 2022.PubMed/NCBI View Article : Google Scholar

Shinjyo N, Kagaya W and Pekna M: Interaction between the complement system and infectious agents-A potential mechanistic link to neurodegeneration and dementia. Front Cell Neurosci. 15(710390)2021.PubMed/NCBI View Article : Google Scholar

Blackhurst BM and Funk KE: Viral pathogens increase risk of neurodegenerative disease. Nat Rev Neurol. 19:259–260. 2023.PubMed/NCBI View Article : Google Scholar

Ogawa H, Fujikura D, Namba H, Yamashita N, Honda T and Yamada M: Nectin-2 acts as a viral entry mediated molecule that binds to human herpesvirus 6B Glycoprotein B. Viruses. 14(160)2022.PubMed/NCBI View Article : Google Scholar

Blujus JK, Korthauer LE, Awe E, Frahmand M and Driscoll I: Single nucleotide polymorphisms in Alzheimer's disease risk genes are associated with intrinsic connectivity in middle age. J Alzheimers Dis. 78:309–320. 2020.PubMed/NCBI View Article : Google Scholar

Gu X, Dou M, Cao B, Jiang Z and Chen Y: Peripheral level of CD33 and Alzheimer's disease: A bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 12(427)2022.PubMed/NCBI View Article : Google Scholar

Gouda NA, Elkamhawy A and Cho J: Emerging therapeutic strategies for Parkinson's disease and future prospects: A 2021 update. Biomedicines. 10(371)2022.PubMed/NCBI View Article : Google Scholar

Petrijan T, Zmazek J and Menih M: Parkinson's disease non-motor subtypes classification in a group of Slovenian patients: Actuarial vs. data-driven approach. J Clin Med. 12(7434)2023.PubMed/NCBI View Article : Google Scholar

Gonzalez-Latapi P, Bayram E, Litvan I and Marras C: Cognitive impairment in Parkinson's disease: Epidemiology, clinical profile, protective and risk factors. Behav Sci (Basel). 11(74)2021.PubMed/NCBI View Article : Google Scholar

Aldridge GM, Birnschein A, Denburg NL and Narayanan NS: Parkinson's disease dementia and dementia with Lewy bodies have similar neuropsychological profiles. Front Neurol. 9(123)2018.PubMed/NCBI View Article : Google Scholar

Woulfe J, Hoogendoorn H, Tarnopolsky M and Muñoz DG: Monoclonal antibodies against Epstein-Barr virus cross-react with alpha-synuclein in human brain. Neurology. 55:1398–1401. 2000.PubMed/NCBI View Article : Google Scholar

Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, et al: The association between infectious burden and Parkinson's disease: A case-control study. Parkinsonism Relat Disord. 21:877–881. 2015.PubMed/NCBI View Article : Google Scholar

Funayama M, Nishioka K, Li Y and Hattori N: Molecular genetics of Parkinson's disease: Contributions and global trends. J Hum Genet. 68:125–130. 2023.PubMed/NCBI View Article : Google Scholar

Solomon AJ, Marrie RA, Viswanathan S, Correale J, Magyari M, Robertson NP, Saylor DR, Kaye W, Rechtman L, Bae E, et al: Global barriers to the diagnosis of multiple sclerosis: Data from the multiple sclerosis International Federation Atlas of MS, Third Edition. Neurology. 101:e624–e635. 2023.PubMed/NCBI View Article : Google Scholar

Qian Z, Li Y, Guan Z, Guo P, Zheng K, Du Y, Yin S, Chen B, Wang H, Jiang J, et al: Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019. Front Public Health. 11(1073278)2023.PubMed/NCBI View Article : Google Scholar

Gustavsen S, Olsson A, Søndergaard HB, Andresen SR, Sørensen PS, Sellebjerg F and Oturai A: The association of selected multiple sclerosis symptoms with disability and quality of life: A large Danish self-report survey. BMC Neurol. 21(317)2021.PubMed/NCBI View Article : Google Scholar

Zeydan B and Kantarci OH: Progressive forms of multiple sclerosis: Distinct entity or age-dependent phenomena. Neurol Clin. 36:163–171. 2018.PubMed/NCBI View Article : Google Scholar

Mato-Abad V, Labiano-Fontcuberta A, Rodríguez-Yáñez S, García-Vázquez R, Munteanu CR, Andrade-Garda J, Domingo-Santos A, Galán Sánchez-Seco V, Aladro Y, Martínez-Ginés ML, et al: Classification of radiologically isolated syndrome and clinically isolated syndrome with machine-learning techniques. Eur J Neurol. 26:1000–1005. 2019.PubMed/NCBI View Article : Google Scholar

Nourbakhsh B and Mowry EM: Multiple sclerosis risk factors and pathogenesis. Continuum (Minneap Minn). 25:596–610. 2019.PubMed/NCBI View Article : Google Scholar

Bar-Or A, Banwell B, Berger JR and Lieberman PM: Guilty by association: Epstein-Barr virus in multiple sclerosis. Nat Med. 28:904–906. 2022.PubMed/NCBI View Article : Google Scholar

Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL and Ascherio A: Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 375:296–301. 2022.PubMed/NCBI View Article : Google Scholar

Pender MP, Csurhes PA, Burrows JM and Burrows SR: Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clin Transl Immunology. 6(e126)2017.PubMed/NCBI View Article : Google Scholar

Soldan SS and Lieberman PM: Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol. 21:51–64. 2023.PubMed/NCBI View Article : Google Scholar

van Langelaar J, Wierenga-Wolf AF, Samijn JPA, Luijks CJM, Siepman TA, van Doorn PA, Bell A, van Zelm MC, Smolders J and van Luijn MM: The association of Epstein-Barr virus infection with CXCR3+ B-cell development in multiple sclerosis: Impact of immunotherapies. Eur J Immunol. 51:626–633. 2021.PubMed/NCBI View Article : Google Scholar

Afrasiabi A, Parnell GP, Fewings N, Schibeci SD, Basuki MA, Chandramohan R, Zhou Y, Taylor B, Brown DA, Swaminathan S, et al: Evidence from genome-wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility. Genome Med. 11(26)2019.PubMed/NCBI View Article : Google Scholar

Sadigh-Eteghad S, Abbasi Garravnd N, Feizollahi M and Talebi M: The expanded disability status scale score and demographic indexes are correlated with the severity of cognitive impairment in multiple sclerosis patients. J Clin Neurol. 17:113–120. 2021.PubMed/NCBI View Article : Google Scholar

Brochet B and Ruet A: Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes. Front Neurol. 10(261)2019.PubMed/NCBI View Article : Google Scholar

DeLuca GC, Yates RL, Beale H and Morrow SA: Cognitive impairment in multiple sclerosis: Clinical, radiologic and pathologic insights. Brain Pathol. 25:79–98. 2015.PubMed/NCBI View Article : Google Scholar

Benedict RHB, Amato MP, DeLuca J and Geurts JJG: Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. Lancet Neurol. 19:860–871. 2020.PubMed/NCBI View Article : Google Scholar

Nacu-Florescu AI, Schreiner OD and Schreiner TG: Screening tests for the evaluation of cognitive impairment in multiple sclerosis patients. Ro J Neurol 21(4). doi.org/10.37897/RJN.2022.4.1.

Aloisi F, Giovannoni G and Salvetti M: Epstein-Barr virus as a cause of multiple sclerosis: Opportunities for prevention and therapy. Lancet Neurol. 22:338–349. 2023.PubMed/NCBI View Article : Google Scholar

Vindegaard N, Petersen LV, Lyng-Rasmussen BI, Dalsgaard S and Benros ME: Infectious mononucleosis as a risk factor for depression: A nationwide cohort study. Brain Behav Immun. 94:259–265. 2021.PubMed/NCBI View Article : Google Scholar

Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, et al: Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature. 603:321–327. 2022.PubMed/NCBI View Article : Google Scholar

Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, et al: Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat Genet. 50:699–707. 2018.PubMed/NCBI View Article : Google Scholar

Virtanen JO, Wohler J, Fenton K, Reich DS and Jacobson S: Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings. Mult Scler. 20:27–34. 2014.PubMed/NCBI View Article : Google Scholar

Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, et al: Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog. 9(e1003220)2013.PubMed/NCBI View Article : Google Scholar

Pavlasova G and Mraz M: The regulation and function of CD20: An ‘enigma’ of B-cell biology and targeted therapy. Haematologica. 105:1494–1506. 2020.PubMed/NCBI View Article : Google Scholar

de Sèze J, Maillart E, Gueguen A, Laplaud DA, Michel L, Thouvenot E, Zephir H, Zimmer L, Biotti D and Liblau R: Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic. Front Immunol. 14(1004795)2023.PubMed/NCBI View Article : Google Scholar

Berger JR and Kakara M: The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis. Mult Scler Relat Disord. 59(103678)2022.PubMed/NCBI View Article : Google Scholar

Mazziotta C, Tognon M, Martini F, Torreggiani E and Rotondo JC: Probiotics mechanism of action on immune cells and beneficial effects on human health. Cells. 12(184)2023.PubMed/NCBI View Article : Google Scholar

Hori T, Matsuda K and Oishi K: Probiotics: A dietary factor to modulate the gut microbiome, host immune system, and gut-brain interaction. Microorganisms. 8(1401)2020.PubMed/NCBI View Article : Google Scholar

Intili G, Paladino L, Rappa F, Alberti G, Plicato A, Calabrò F, Fucarino A, Cappello F, Bucchieri F, Tomasello G, et al: From dysbiosis to neurodegenerative diseases through different communication pathways: An overview. Biology (Basel). 12(195)2023.PubMed/NCBI View Article : Google Scholar